title: MEK1/2 inhibition delays progression of uveal melanoma.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Gilbert
mesh_terms: D006801:Humans; D000284:Administration, Oral; D001562:Benzimidazoles / Q000008:administration & dosage; D016001:Confidence Intervals; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D048369:MAP Kinase Kinase 1 / Q000187:drug effects; D048370:MAP Kinase Kinase 2 / Q000187:drug effects; D058990:Molecular Targeted Therapy / Q000379:methods; D011379:Prognosis; D016016:Proportional Hazards Models; D016896:Treatment Outcome; D014604:Uveal Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: C517975:AZD 6244; D001562:Benzimidazoles; D048369:MAP Kinase Kinase 1; D048370:MAP Kinase Kinase 2